Flowserve Corporation Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Flowserve Corporation Common Stock trades at $72.28 (market cap $8.85B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.9× Flowserve Corporation Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| FLS | RPRX | |
|---|---|---|
Market Cap | $8.85B | $25.27B |
Volume | 1,955,324 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $92.04 | $63.96 |
52-Week Low | $49.09 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.44B | $32.50B |
Dividend Yield | 1.26% | 1.66% |
Trailing returns across standard periods
Latest headlines on both assets
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →